EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Historical Perspective and Current Trends in Anticancer Drug Development

Katarzyna Gach-Janczak iD, Joanna Drogosz-Stachowicz, Anna Janecka, Karol Wtorek, Marek Mirowski iD

Cancers · 15.05.2024 · 16 (10) · 1878

DOI: 10.3390/cancers16101878 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 15.05.2024. Verfasst von Katarzyna Gach-Janczak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz, Medical University of Lodz, Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer is considered one of the leading causes of death in the 21st century. The intensive search for new anticancer drugs has been actively pursued by chemists and pharmacologists for decades, focusing either on the isolation of compounds with cytotoxic properties from plants or on screening thousands of synthetic molecules. Compounds that could potentially become candidates for new anticancer drugs must have the ability to inhibit proliferation and/or induce apoptosis in cancer cells without causing too much damage to normal cells. Some anticancer compounds were discovered by accident, others as a result of long-term research. In this review, we have presented a brief history of the development of the most important groups of anticancer drugs, pointing to the fact that they all have many side effects.

Schlagwörter

Stichwörter der Autor:innen

alkylating agentscancer chemotherapyintercalating agentskinase inhibitorsmitotic disruptors

Autor:innen und Institutionen

  • Department of Biomolecular Chemistry, Medical University of Lodz, Mazowiecka 6/8, 92-215 Lodz, Poland.
  • Clinical Trials Support Unit, Medical University of Lodz, Pomorska 251, 92-215 Lodz, Poland.
  • Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland.

ORCID-Profile: Katarzyna Gach-Janczak, Marek Mirowski

Förderung

  • Medical University of Lodz
  • Medical University of Lodz, Poland

Zitieren

APA

Gach-Janczak, K., Drogosz-Stachowicz, J., Janecka, A., Wtorek, K., & Mirowski, M. (2024). Historical Perspective and Current Trends in Anticancer Drug Development. Cancers, 16(10), 1878. https://doi.org/10.3390/cancers16101878

Vancouver

Gach-Janczak K, Drogosz-Stachowicz J, Janecka A, Wtorek K, Mirowski M. Historical Perspective and Current Trends in Anticancer Drug Development. Cancers. 2024;16(10):1878. doi:10.3390/cancers16101878

BibTeX
@article{GachJanczak2024,
  author = {Gach-Janczak, Katarzyna and Drogosz-Stachowicz, Joanna and Janecka, Anna and Wtorek, Karol and Mirowski, Marek},
  title = {Historical Perspective and Current Trends in Anticancer Drug Development},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {10},
  pages = {1878},
  doi = {10.3390/cancers16101878}
}
Kostenlos starten →